SKU: T13202L-5mg-TM
Trilaciclib
Blue Ice
Specifications
| Specification | Details |
|---|---|
| Additional Information | Trilaciclib is a short-acting, orally effective CDK4/6 inhibitor with IC₅₀ values of 1 nM and 4 nM respectively. It transiently and reversibly induces G1 cell cycle arrest, mitigates chemotherapy-induced myelosuppression, and enhances antitumour immunity, making it applicable across multiple cancers. |
Resources
PDF
Datasheet
Catalog Number
T13202L-5mg-TM
Name
Trilaciclib
Price(5 mg)
Pack Size